Refractory gastro-oesophageal reflux disease: diagnosis and management
- PMID: 19747009
- DOI: 10.2165/11318520-000000000-00000
Refractory gastro-oesophageal reflux disease: diagnosis and management
Abstract
Refractory gastro-oesophageal reflux disease (GORD) is described when reflux symptoms have not responded to 4-8 weeks of proton pump inhibitor therapy and occurs in a heterogeneous mixture of patients. The causes of refractory GORD include inadequate acid suppression, non-acid gastro-oesophageal reflux, and non-reflux causes of GORD symptoms including achalasia, gastroparesis and functional heartburn. Upper gastrointestinal tract endoscopy should initially be performed to identify the presence of oesophagitis, and exclude other diagnoses including eosinophilic oesophagitis and peptic ulcer disease. Patients with refractory symptoms but with a normal upper endoscopy are more difficult to diagnose and may require ambulatory pH monitoring, impedance testing, oesophageal motility tests and gastric emptying scans. The primary goal of treatment is symptom reduction and eventual elimination, which can be achieved with proper identification of the underlying cause of the symptoms.
Similar articles
-
Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity.Aliment Pharmacol Ther. 2018 Apr;47(7):958-965. doi: 10.1111/apt.14528. Epub 2018 Jan 26. Aliment Pharmacol Ther. 2018. PMID: 29372566
-
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2. Dis Esophagus. 2013. PMID: 22862422
-
Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.Drugs. 2005;65 Suppl 1:35-42. doi: 10.2165/00003495-200565001-00006. Drugs. 2005. PMID: 16335856 Review.
-
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4. Arq Gastroenterol. 2018. PMID: 30304291 Review.
-
Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.Curr Opin Gastroenterol. 2013 Jul;29(4):431-6. doi: 10.1097/MOG.0b013e328360433c. Curr Opin Gastroenterol. 2013. PMID: 23549342 Review.
Cited by
-
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.Clin Exp Gastroenterol. 2018 Mar 21;11:119-134. doi: 10.2147/CEG.S121056. eCollection 2018. Clin Exp Gastroenterol. 2018. PMID: 29606884 Free PMC article. Review.
-
Novel Surgical Treatments for Gastroesophageal Reflux Disease: Systematic Review of Magnetic Sphincter Augmentation and Electric Stimulation Therapy.Gastroenterology Res. 2018 Jun;11(3):161-173. doi: 10.14740/gr1024w. Epub 2018 May 31. Gastroenterology Res. 2018. PMID: 29915626 Free PMC article. Review.
-
Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.World J Gastroenterol. 2013 Jul 21;19(27):4386-92. doi: 10.3748/wjg.v19.i27.4386. World J Gastroenterol. 2013. PMID: 23885151 Free PMC article.
-
How to diagnose GERC more effectively: reflections on post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance.BMC Pulm Med. 2024 Jun 5;24(1):269. doi: 10.1186/s12890-024-03080-z. BMC Pulm Med. 2024. PMID: 38840152 Free PMC article.
-
Diagnosis and treatment of patients with nonacid gastroesophageal reflux-induced chronic cough.J Res Med Sci. 2015 Sep;20(9):885-92. doi: 10.4103/1735-1995.170625. J Res Med Sci. 2015. PMID: 26759577 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical